Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure

Journal of Clinical Investigation

Volumn 123, Issue 7, 2013, Pages 2816-2831

  Cutando, Laura ^a   Busquets Garcia, Arnau ^a   Puighermanal, Emma ^a   Gomis González, Maria ^a   Delgado García, José María ^b   Gruart, Agnès ^b   Maldonado, Rafael ^a   Ozaita, Andrés ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CD11B ANTIGEN; DRONABINOL; INTERLEUKIN 1BETA; MESSENGER RNA; MINOCYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLAR FUNCTION; CEREBELLUM; CEREBELLUM DISEASE; CONTROLLED STUDY; FINE MOTOR COORDINATION; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEARNING; MALE; MICROGLIAL ACTIVATION; MOLECULAR MECHANICS; MOTOR COORDINATION; MOUSE; NERVE FIBER; NERVE FUNCTION; NERVOUS SYSTEM FUNCTION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD11B; CANNABINOID RECEPTOR AGONISTS; CEREBELLAR DISEASES; CEREBELLUM; CONDITIONING, EYELID; DRONABINOL; GENE EXPRESSION; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; PSYCHOMOTOR PERFORMANCE; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 84879664081     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67569     Document Type: Article

References (54)

1. Degenhardt L, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med.2008;5(7):e141.
2. Pertwee RG. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol. 2009;156(3):397-411.
3. Kano M, et al. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev. 2009;89(1):309-380.
4. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61-65. (Pubitemid 23305569)
5. Van Sickle MD, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310(5746):329-332. (Pubitemid 41457202)
6. Maresz K, et al. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem. 2005;95(2):437-445. (Pubitemid 41457512)
7. Bisogno T, Di Marzo V. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol Disord Drug Targets. 2010;9(5):564-573.
8. Sim-Selley LJ. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol. 2003;15(2):91-119. (Pubitemid 38160440)
9. Villares J. Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience. 2007;145(1):323-334. (Pubitemid 46237689)
10. Romero J, et al. Effects of chronic exposure to delta9- tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res. 1997;46(1-2):100-108. (Pubitemid 27214360)
11. Kawamura Y, et al. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci. 2006;26(11):2991-3001.
12. Carey MR, et al. Presynaptic CB1 receptors regulate synaptic plasticity at cerebellar parallel fiber synapses. J Neurophysiol. 2011;105(2):958-963.
13. Thompson RF, Kim JJ. Memory systems in the brain and localization of a memory. Proc Natl Acad Sci U S A. 1996;93(24):13438-13444. (Pubitemid 26424139)
14. Tonini R, Ciardo S, Cerovic M. ERK-dependent modulation of cerebellar synaptic plasticity after chronic delta9-tetrahydrocannabinol exposure. J Neurosci. 2006;26(21):5810-5818. (Pubitemid 44315274)
15. Skosnik PD, et al. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning. Neuropsychopharmacology. 2008;33(6):1432-1440. (Pubitemid 351521714)
16. Edwards CR, et al. Assessment of forebrain-dependent trace eyeblink conditioning in chronic cannabis users. Neurosci Lett. 2008;18(3):264-268.
17. Kishimoto Y, Kano M. Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning. J Neurosci. 2006;26(34):8829-8837. (Pubitemid 44319418)
18. Steinmetz AB, et al. Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans. Psychopharmacology. 2012;221(1):133-141.
19. Edwards CR, Skosnik PD. Cerebellar-dependent learning as a neurobehavioral index of the cannabinoid system. Crit Rev Neurobiol. 2007;19(1):29-57.
20. Stella N. Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010;58(9):1017-1030.
21. Garden GA, Möller T. Microglia biology in health and disease. J Neuroimmune Pharmacol. 2006;1(2):127-137. (Pubitemid 44257488)
22. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314-1318. (Pubitemid 40746128)
23. Wake H, Moorhouse AJ, Jinno S. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci. 2009;29(13):3974-3980.
24. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia.2002;40(2):133-139. (Pubitemid 35337371)
25. Pocock JM, Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007;30(10):527-535. (Pubitemid 47513237)
26. Färber K, Kettenmann H. Physiology of microglial cells. Brain Res Brain Res Rev. 2005;48(2):133-143.
27. Kaushal V, Schlichter LC. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci. 2008;28(9):2221-2230. (Pubitemid 351317617)
28. Yenari MA, Kauppinen TM, Swanson RA. Microglial activation in stroke: therapeutic targets. Neurotherapeutics. 2010;7(4):378-391.
29. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 1996;19(8):312-318. (Pubitemid 26349059)
30. Colton CA, Wilcock DM. Assessing activation states in microglia. CNS Neurol Disord Drug Targets. 2010;9(2):174-191.
31. Hutcheson DM, Tzavara ET, Smadja C. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9- tetrahydrocannabinol. Br J Pharmacol. 1998;125(7):1567-1577. (Pubitemid 28548570)
32. Thompson RF, Steinmetz JE. The role of the cerebellum in classical conditioning of discrete behavioral responses. Neuroscience. 2009;162(3):732-755.
33. Jiménez-Díaz L, et al. Role of cerebellar interpositus nucleus in the genesis and control of reflex and conditioned eyelid responses. J Neurosci. 2004;24(41):9138-9145.
34. Morcuende S, Delgado-Garcia JM, Ugolini G. Neuronal premotor networks involved in eyelid responses: retrograde transneuronal tracing with rabies virus from the orbicularis oculi muscle in the rat. J Neurosci. 2002;22(20):8808- 8818. (Pubitemid 35379050)
35. Tikka T, et al. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci. 2001;21(8):2580-2588. (Pubitemid 32298200)
36. Bilkei-Gorzo A, et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci U S A. 2005;102(51):15670-15675. (Pubitemid 41528114)
37. Andoh T, Kishi H, Motoki K, et al. Protective effect of IL-18 on kainate- and IL-1 beta-induced cerebellar ataxia in mice. J Immunol. 2008;180(4):2322-2328.
38. Motoki K, et al. The direct excitatory effect of IL-1beta on cerebellar Purkinje cell. Biochem Biophys Res Commun. 2009;379(3):665-668.
39. French RA, et al. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol. 1999;93(1-2):194-202. (Pubitemid 29051565)
40. Kim S, Thompson RF. c-Fos, Arc, and stargazin expression in rat eyeblink conditioning. Behav Neurosci. 2011;125(1):117-123.
41. Zhuang S, et al. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions. Brain Res Mol Brain Res. 1998;62(2):141-149. (Pubitemid 29010381)
42. Torres E, et al. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain. J Neurochem. 2010;113(1):67-78.
43. Ramírez BG, et al. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci. 2005;25(8):1904-1913.
44. Albayram O, et al. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc Natl Acad Sci U S A. 2011;108(27):11256-11261.
45. Chu LS, et al. Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sci. 2010;86(5-6):170-177.
46. Zhao ML, et al. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol. 2001;115(1-2):182-191.
47. Xu-Friedman MA, Harris KM, Regehr WG. Three-dimensional comparison of ultrastructural characteristics at depressing and facilitating synapses onto cerebellar Purkinje cells. J Neurosci. 2001;21(17):6666-6672. (Pubitemid 32781111)
48. Barbour B, Keller BU, Llano I. Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. Neuron. 1994;12(6):1331-1343. (Pubitemid 24186800)
49. Marcaggi P, Attwell D. Endocannabinoid signaling depends on the spatial pattern of synapse activation. Nat Neurosci. 2005;8(6):776-781. (Pubitemid 43085844)
50. Chang L, et al. Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain. 2006;129(pt 5):1096-1112.
51. Ledent C, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science. 1999;283(5400):401- 404.
52. Marsicano G, et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science. 2003;302(5642):84-88. (Pubitemid 37210691)
53. Ozaita A, Puighermanal E, Maldonado R. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J Neurochem. 2007;102(4):1105-1114. (Pubitemid 47174245)
54. Puighermanal E, et al. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci. 2009;12(9):1152-1158.